Oramed Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Oramed Pharmaceuticals

08/05/2024 03:04

* Oramed Pharmaceuticals Inc  ORMP.OQ   ORMP.O  is expected
to show a fall in quarterly revenue when it reports  results on
May 9 (estimated) for the period ending January 1 0001
    * The New York City-based  company is expected to report a
24.9% decrease in revenue to $500 thousand from $666 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Oramed Pharmaceuticals
Inc is
for earnings of 2 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Oramed
Pharmaceuticals Inc is $4.25​, above​ its last closing price
of $2.40. ​​​

This summary was machine generated May 8 at 02:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)